Marinus Pharmaceuticals
ID: 5290728A biopharmaceutical company developing ganaxolone for the treatment of drug-resistant seizures and neuropsychiatric disorders
2
Funding Rounds
$41.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| El** Ez****** | - | - | |
| Ni**** Vi***** | - | - | - |
| Sc*** Br******** | - | - | |
| Se** H.** Fi***** | - | - | |
| Sa****** Ar**** | - | - | |
| Ti* M. Ma****** | - | - | |
| Sa** No**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Marinus Pharmaceuticals has raised a total of $41m in funding over 2 rounds.
Key Insights:
- Marinus Pharmaceuticals Series C round: $21m
- Marinus Pharmaceuticals Series B round: $20m
Industries
Marinus Pharmaceuticals is active in the following industries: